DIVISLAB had a strong weekly performance, returning 2.64% with a Sharpe Ratio of 1.51, indicating a favorable risk-return tradeoff. The stock's volatility was relatively low at 9.15%, making it a less risky investment option. Compared to its peers, DIVISLAB outperformed DRREDDY and significantly outperformed SUNPHARMA, while slightly underperforming CIPLA. Overall, the stock demonstrated a robust performance with manageable risk.

[Volatility: 9.15%]